Molecule found to boost immune cells leads to new cancer therapy target
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
List view / Grid view
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
A study has shown that the organisation of the gut is broken into functional compartments, improving opportunities for gastrointestinal disorder drugs and oral vaccines.
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.
New study describes for the first time the structure of Ixolaris and its action on the inhibition of thrombus formation.
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.
The SCIB2 vaccine is to to be administered using new nanoparticle formulation in planned Phase 1/2 clinical trial.
Researchers find key molecule in depression and identify new therapeutic targets.
The global gene editing tools market is estimated to have accounted for more than US$258 million in terms of value in 2018.
New findings could be translated into the development of novel treatments for patients with optic neuropathies.
A new method of assessing the actions of medicines by matching them to their unique protein receptors could accelerate drug development.
Findings from a recent study could lead to the development of therapeutic approaches against influenza A viruses.
Researchers have discovered an acid-activated protein which could stop damage to tissues as a result of stroke and other health issues.
Researchers have shown how skin vaccinations could be used as a vaccination strategy for sexually transmitted infections (STIs).
A new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs has been developed.
Scientists have discovered an unexpected weakness in the influenza virus protein.